5,8,11-eicosatrienoic acid

5,8,11-eicosatrienoic acid is a lipid of Fatty Acyls (FA) class. 5,8,11-eicosatrienoic acid is associated with abnormalities such as Pulmonary Eosinophilia. The involved functions are known as antagonists, actin polymerization, release of sequestered calcium ion into cytoplasm, Neutrophil migration, function and Chemotaxis. 5,8,11-eicosatrienoic acid often locates in Cytoplasmic matrix and Back. The associated genes with 5,8,11-eicosatrienoic acid are Homologous Gene, IMPACT gene and ALOX12 gene. The related lipids are Fatty Acids and Eicosatrienoic Acid.

Cross Reference

Introduction

To understand associated biological information of 5,8,11-eicosatrienoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 5,8,11-eicosatrienoic acid?

5,8,11-eicosatrienoic acid is suspected in Pulmonary Eosinophilia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 5,8,11-eicosatrienoic acid

MeSH term MeSH ID Detail
Inflammatory Bowel Diseases D015212 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Atherosclerosis D050197 85 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 5,8,11-eicosatrienoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 5,8,11-eicosatrienoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 5,8,11-eicosatrienoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 5,8,11-eicosatrienoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 5,8,11-eicosatrienoic acid

Download all related citations
Per page 10 20 50 100 | Total 59
Authors Title Published Journal PubMed Link
Paassilta M et al. Food allergy in small children carries a risk of essential fatty acid deficiency, as detected by elevated serum mead acid proportion of total fatty acids. 2014 Lipids Health Dis pmid:25440954
Ichi I et al. Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency. 2014 Biochim. Biophys. Acta pmid:24184513
Hamazaki T et al. Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22521862
Astarita G et al. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. 2011 PLoS ONE pmid:22046234
van Goor SA et al. Mildly abnormal general movement quality in infants is associated with higher Mead acid and lower arachidonic acid and shows a U-shaped relation with the DHA/AA ratio. 2010 Prostaglandins Leukot. Essent. Fatty Acids pmid:20022733
Karaman IuK et al. [The role of modification of fatty acid composition of erythrocyte lipids in pathogenesis of arterial hypertension]. 2010 Kardiologiia pmid:20659041
Hamazaki T et al. The depressive effects of 5,8,11-eicosatrienoic Acid (20:3n-9) on osteoblasts. 2009 Lipids pmid:18941818
Coste TC et al. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. 2008 Clin. Chem. pmid:18089657
Patel P et al. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity. 2008 J. Pharmacol. Exp. Ther. pmid:18292294
Strijbosch RA et al. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. 2008 Metab. Clin. Exp. pmid:18442636
Nakano N et al. Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells. 2005 Biochim. Biophys. Acta pmid:16403671
Yoshida H et al. Beneficial effects of n-9 eicosatrienoic acid on experimental bowel lesions. 2003 Surg. Today pmid:12884098
Heyd VL and Eynard AR Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. 2003 Prostaglandins Other Lipid Mediat. pmid:14518560
Fokkema MR et al. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12445496
Sakuradani E et al. Production of 5,8,11-eicosatrienoic acid by a delta5 and delta6 desaturation activity-enhanced mutant derived from a delta12 desaturation activity-defective mutant of Mortierella alpina 1S-4. 2002 Appl. Microbiol. Biotechnol. pmid:12436308
Kanda H et al. Inhibitors of arachidonic acid metabolism have variable effects on calcium signaling pathways. 2001 Am. J. Hypertens. pmid:11281236
Oliw EH et al. Oxygenation of 5,8,11-eicosatrienoic acid by prostaglandin H synthase-2 of ovine placental cotyledons: isolation of 13-hydroxy-5,8,11-eicosatrienoic and 11-hydroxy-5,8,12-eicosatrienoic acids. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9106061
Kuroki F et al. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. 1997 Dig. Dis. Sci. pmid:9201073
Cleland LG et al. Dietary (n-9) eicosatrienoic acid from a cultured fungus inhibits leukotriene B4 synthesis in rats and the effect is modified by dietary linoleic acid. 1996 J. Nutr. pmid:8648425
Cleland LG et al. Effect of dietary n-9 eicosatrienoic acid on the fatty acid composition of plasma lipid fractions and tissue phospholipids. 1996 Lipids pmid:8869885
Farquharson J et al. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. 1995 Arch. Dis. Child. pmid:7741563
Retterstøl K et al. Studies on the metabolism of [1-14C]5.8.11-eicosatrienoic (Mead) acid in rat hepatocytes. 1995 Biochim. Biophys. Acta pmid:7492619
Oliw EH et al. Oxygenation of 5,8,11-eicosatrienoic acid by prostaglandin endoperoxide synthase and by cytochrome P450 monooxygenase: structure and mechanism of formation of major metabolites. 1993 Arch. Biochem. Biophys. pmid:8373167
James MJ et al. Effect of dietary supplementation with n-9 eicosatrienoic acid on leukotriene B4 synthesis in rats: a novel approach to inhibition of eicosanoid synthesis. 1993 J. Exp. Med. pmid:8245797
Ghebremeskel K and Leighfield M Infant brain lipids and diet. 1992 Lancet pmid:1357473
Adkisson HD et al. Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. 1991 FASEB J. pmid:2001795
Garcia MC et al. Chain elongation of polyunsaturated fatty acids by vascular endothelial cells: studies with arachidonate analogues. 1990 Lipids pmid:2345494
Christon R et al. Modification of fluidity and lipid-protein relationships in pig intestinal brush-border membrane by dietary essential fatty acid deficiency. 1989 Biochim. Biophys. Acta pmid:2538158
Cotter R et al. Fatty acid profiles in response to soybean oil lipid emulsion infusions in essential fatty acid-deficient miniature swine. 1988 Mar-Apr JPEN J Parenter Enteral Nutr pmid:3129587
Farrell PM et al. Essential fatty acid deficiency in premature infants. 1988 Am. J. Clin. Nutr. pmid:3407602
Ohata K and Kohno S [Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents]. 1987 Nippon Rinsho pmid:2824881
Banerjee N and Rosenthal MD Elongation of C20 polyunsaturated fatty acids by human skin fibroblasts. 1986 Biochim. Biophys. Acta pmid:3019415
Elliott WJ et al. Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system. 1986 J. Biol. Chem. pmid:3084488
Reich R et al. Ovarian lipoxygenase activity and its regulation by gonadotropin in the rat. 1985 Prostaglandins pmid:3936117
Sicard B and Lagarde M Incorporation of some eicosanoic acids into endothelial cells--effect on platelet inhibitory activity and prostacyclin production. 1985 Thromb. Haemost. pmid:2992114
Lagarde M et al. Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. 1985 FEBS Lett. pmid:3918886
Banerjee N and Rosenthal MD High-affinity incorporation of 20-carbon polyunsaturated fatty acids by human skin fibroblasts. 1985 Biochim. Biophys. Acta pmid:2990563
Weiner TW and Sprecher H Arachidonic acid, 5,8,11-eicosatrienoic acid and 5,8,11,14, 17-eicosapentaenoic acid. Dietary manipulation of the levels of these acids in rat liver and platelet phospholipids and their incorporation into human platelet lipids. 1984 Biochim. Biophys. Acta pmid:6320899
Stenson WF et al. Leukotriene B formation by neutrophils from essential fatty acid-deficient rats. 1984 J. Biol. Chem. pmid:6090446
Kaplan HB et al. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. 1984 Biochem. Pharmacol. pmid:6422946
Kühn H et al. The inactivation of lipoxygenases by acetylenic fatty acids. 1984 Biomed. Biochim. Acta pmid:6440550
Jakschik BA et al. Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway. 1983 J. Biol. Chem. pmid:6313677
Lagarde M et al. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. 1983 Lipids pmid:6408333
Neufeld EJ et al. High affinity esterification of eicosanoid precursor fatty acids by platelets. 1983 J. Clin. Invest. pmid:6308046
Nubé M et al. Energy intake and the appearance of 5,8,11-eicosatrienoic acid in serum lipids during parenteral nutrition without fat. 1982 Mar-Apr JPEN J Parenter Enteral Nutr pmid:6808172
Orning L et al. Formation of leukotrienes E3, E4 and E5 in rat basophilic leukemia cells. 1981 Eur. J. Biochem. pmid:6273168
Hammarström S Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. 1981 J. Biol. Chem. pmid:6780563
Barr LH et al. Essential fatty acid deficiency during total parenteral nutrition. 1981 Ann. Surg. pmid:6782957
Nguyen TT et al. New model of a scaling dermatosis: induction of hyperproliferation in hairless mice with eicosa-5,8,11-trienoic acid. 1981 J. Invest. Dermatol. pmid:7229430
Kroegel C et al. Inhibition of the eosinophil chemotactic factor (ECF) release from human PMNs and rat mast cells by arachidonic acid analogs. 1981 Cell. Immunol. pmid:7237570